Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ragweed MATA MPL Efficacy in Ragweed Allergy
NCT00423787Phase 3Completed
- Sponsor
- Allergy Therapeutics PLC
- Start
- Mar 2007
- Primary completion
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of Pollinex Quattro Ragweed in ragweed allergy, sponsored by Allergy Therapeutics PLC. Started Mar 2007; status: completed.
02
Drugs
Pollinex Quattro Ragweed
03
Conditions
ragweed allergy
Beyond the preview
Go deeper on NCT00423787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423787.